Related Experiment Video
Updated: Jun 26, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
P53 mRNA controls p53 activity by managing Mdm2 functions
Marco M Candeias1, Laurence Malbert-Colas, Darren J Powell
1Inserm U716, Pharmacologie Expérimentale, Institut Génétique Moléculaire, Hôpital St Louis and Université Paris 7, 27 rue Juliette Dodu, 75010 Paris, France.
Abstract:
The E3 ubiquitin ligase Mdm2 is a focal regulator of p53 tumour suppressor activity. It binds p53, promoting its polyubiquitination and degradation, and also controls p53 synthesis. However, it is not known how this dual function of Mdm2 on p53 synthesis and degradation is achieved. Here we show that the p53 mRNA region encoding the Mdm2-binding site interacts directly with the RING domain of Mdm2. This impairs the E3 ligase activity of Mdm2 and promotes p53 mRNA translation. We also show that introduction of cancer-derived single silent point-mutations in the p53 mRNA weakens its binding to Mdm2 and results in reduced p53 activity. These data are consistent with a mechanism by which changes in silent nucleotides can affect the function of the encoded protein, and indicate that Mdm2-mediated control of p53 synthesis and degradation has evolved in the p53 mRNA sequence and its encoded amino acids.
Insights
The E3 ubiquitin ligase Mdm2 regulates tumor suppressor p53. Mdm2 binding to p53 mRNA enhances p53 translation and reduces degradation, with silent mutations impacting this regulation.
Area of Science:
- Molecular Biology
- Cancer Research
- Gene Regulation
Background:
- Mdm2 (E3 ubiquitin ligase) is a key regulator of the p53 tumor suppressor.
- Mdm2 controls p53 through both degradation and synthesis.
- The precise mechanism for Mdm2's dual regulation of p53 synthesis and degradation remains unclear.
Purpose of the Study:
- To elucidate the mechanism behind Mdm2's dual regulation of p53 synthesis and degradation.
- To investigate the direct interaction between p53 mRNA and Mdm2.
- To assess the impact of silent mutations in p53 mRNA on Mdm2 binding and p53 activity.
Main Methods:
- RNA-protein interaction assays to study p53 mRNA and Mdm2 binding.
- In vitro assays to assess E3 ligase activity.
- Analysis of p53 mRNA translation and protein degradation.
- Site-directed mutagenesis to introduce silent point mutations in p53 mRNA.
Main Results:
- The p53 mRNA region encoding the Mdm2-binding site directly interacts with Mdm2's RING domain.
- This interaction inhibits Mdm2's E3 ligase activity, thereby promoting p53 mRNA translation.
- Cancer-derived silent point mutations in p53 mRNA weaken Mdm2 binding, leading to reduced p53 activity.
Conclusions:
- Mdm2-mediated control of p53 synthesis and degradation is intrinsically linked to the p53 mRNA sequence.
- Silent nucleotides within p53 mRNA can influence protein function by modulating Mdm2 interactions.
- This highlights a novel layer of gene regulation where mRNA sequence elements dictate protein stability and synthesis.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Inhibition of Cdk Activity
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...

